OnKure files to sell 2.94M shares of Class A Common Stock for holders [Seeking Alpha]
OnKure Therapeutics, Inc. - Class A (OKUR)
Company Research
Source: Seeking Alpha
This prospectus is not an offer to sell. Filing More on OnKure Therapeutics, Inc. OnKure started at outperform by Oppenheimer, OKI-219 potential cited Historical earnings data for OnKure Therapeutics, Inc. Financial information for OnKure Therapeutics, Inc. Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
OKUR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OKUR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OKUR alerts
High impacting OnKure Therapeutics, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
OKUR
News
- Will OnKure Therapeutics (NASDAQ:OKUR) Spend Its Cash Wisely? [Yahoo! Finance]Yahoo! Finance
- OnKure Therapeutics (NASDAQ: OKUR) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $35.00 to $30.00. They now have an "outperform" rating on the stock.MarketBeat
- OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsGlobeNewswire
- OnKure Therapeutics to Present at Upcoming Leerink and Stifel Investor ConferencesGlobeNewswire
OKUR
Sec Filings
- 3/10/25 - Form S-8
- 3/10/25 - Form 424B3
- 3/10/25 - Form 8-K
- OKUR's page on the SEC website